1131 related articles for article (PubMed ID: 30149573)
1. Human Milk Oligosaccharides: 2'-Fucosyllactose (2'-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula.
Vandenplas Y; Berger B; Carnielli VP; Ksiazyk J; Lagström H; Sanchez Luna M; Migacheva N; Mosselmans JM; Picaud JC; Possner M; Singhal A; Wabitsch M
Nutrients; 2018 Aug; 10(9):. PubMed ID: 30149573
[TBL] [Abstract][Full Text] [Related]
2. Human Milk Oligosaccharides Influence Neonatal Mucosal and Systemic Immunity.
Donovan SM; Comstock SS
Ann Nutr Metab; 2016; 69 Suppl 2(Suppl 2):42-51. PubMed ID: 28103609
[TBL] [Abstract][Full Text] [Related]
3. Review of the Clinical Experiences of Feeding Infants Formula Containing the Human Milk Oligosaccharide 2'-Fucosyllactose.
Reverri EJ; Devitt AA; Kajzer JA; Baggs GE; Borschel MW
Nutrients; 2018 Sep; 10(10):. PubMed ID: 30241407
[TBL] [Abstract][Full Text] [Related]
4. Linking Human Milk Oligosaccharides, Infant Fecal Community Types, and Later Risk To Require Antibiotics.
Berger B; Porta N; Foata F; Grathwohl D; Delley M; Moine D; Charpagne A; Siegwald L; Descombes P; Alliet P; Puccio G; Steenhout P; Mercenier A; Sprenger N
mBio; 2020 Mar; 11(2):. PubMed ID: 32184252
[TBL] [Abstract][Full Text] [Related]
5. Human Milk Oligosaccharides: Factors Affecting Their Composition and Their Physiological Significance.
Sprenger N; Binia A; Austin S
Nestle Nutr Inst Workshop Ser; 2019; 90():43-56. PubMed ID: 30865976
[TBL] [Abstract][Full Text] [Related]
6. The Role of Two Human Milk Oligosaccharides, 2'-Fucosyllactose and Lacto-N-Neotetraose, in Infant Nutrition.
Hegar B; Wibowo Y; Basrowi RW; Ranuh RG; Sudarmo SM; Munasir Z; Atthiyah AF; Widodo AD; Supriatmo ; Kadim M; Suryawan A; Diana NR; Manoppo C; Vandenplas Y
Pediatr Gastroenterol Hepatol Nutr; 2019 Jul; 22(4):330-340. PubMed ID: 31338308
[TBL] [Abstract][Full Text] [Related]
7. Human Milk Oligosaccharides and Lactose Differentially Affect Infant Gut Microbiota and Intestinal Barrier In Vitro.
Natividad JM; Marsaux B; Rodenas CLG; Rytz A; Vandevijver G; Marzorati M; Van den Abbeele P; Calatayud M; Rochat F
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745275
[TBL] [Abstract][Full Text] [Related]
8. Real-world study in infants fed with an infant formula with two human milk oligosaccharides.
Román E; Moreno Villares JM; Domínguez Ortega F; Carmona Martínez A; Picó Sirvent L; Santana Sandoval L; Casas Rivero J; Alshweki A; Cercamondi C; Dahbane S; Vidal Guevara ML
Nutr Hosp; 2020 Aug; 37(4):698-706. PubMed ID: 32698596
[TBL] [Abstract][Full Text] [Related]
9. Distinct fermentation of human milk oligosaccharides 3-FL and LNT2 and GOS/inulin by infant gut microbiota and impact on adhesion of
Kong C; Akkerman R; Klostermann CE; Beukema M; Oerlemans MMP; Schols HA; de Vos P
Food Funct; 2021 Dec; 12(24):12513-12525. PubMed ID: 34811557
[TBL] [Abstract][Full Text] [Related]
10. Human Milk Oligosaccharides and Immune System Development.
Plaza-Díaz J; Fontana L; Gil A
Nutrients; 2018 Aug; 10(8):. PubMed ID: 30096792
[TBL] [Abstract][Full Text] [Related]
11. Recent advance in infant nutrition: Human milk oligosaccharides.
Cheng YJ; Yeung CY
Pediatr Neonatol; 2021 Jul; 62(4):347-353. PubMed ID: 33893051
[TBL] [Abstract][Full Text] [Related]
12. Selected Human Milk Oligosaccharides Added to Infant Formulas for Term Infants.
Szajewska H
Nestle Nutr Inst Workshop Ser; 2021; 96():149-159. PubMed ID: 35537422
[TBL] [Abstract][Full Text] [Related]
13. Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota.
Elison E; Vigsnaes LK; Rindom Krogsgaard L; Rasmussen J; Sørensen N; McConnell B; Hennet T; Sommer MO; Bytzer P
Br J Nutr; 2016 Oct; 116(8):1356-1368. PubMed ID: 27719686
[TBL] [Abstract][Full Text] [Related]
14. Clinical Evaluation of 16-Week Supplementation with 5HMO-Mix in Healthy-Term Human Infants to Determine Tolerability, Safety, and Effect on Growth.
Parschat K; Melsaether C; Jäpelt KR; Jennewein S
Nutrients; 2021 Aug; 13(8):. PubMed ID: 34445031
[TBL] [Abstract][Full Text] [Related]
15. Varied Pathways of Infant Gut-Associated
Sakanaka M; Gotoh A; Yoshida K; Odamaki T; Koguchi H; Xiao JZ; Kitaoka M; Katayama T
Nutrients; 2019 Dec; 12(1):. PubMed ID: 31888048
[TBL] [Abstract][Full Text] [Related]
16. Diversification of a Fucosyllactose Transporter within the Genus
Ojima MN; Asao Y; Nakajima A; Katoh T; Kitaoka M; Gotoh A; Hirose J; Urashima T; Fukiya S; Yokota A; Abou Hachem M; Sakanaka M; Katayama T
Appl Environ Microbiol; 2022 Jan; 88(2):e0143721. PubMed ID: 34731055
[TBL] [Abstract][Full Text] [Related]
17. Fucosyllactose and L-fucose utilization of infant Bifidobacterium longum and Bifidobacterium kashiwanohense.
Bunesova V; Lacroix C; Schwab C
BMC Microbiol; 2016 Oct; 16(1):248. PubMed ID: 27782805
[TBL] [Abstract][Full Text] [Related]
18. Infant-gut associated Bifidobacterium dentium strains utilize the galactose moiety and release lacto-N-triose from the human milk oligosaccharides lacto-N-tetraose and lacto-N-neotetraose.
Moya-Gonzálvez EM; Rubio-Del-Campo A; Rodríguez-Díaz J; Yebra MJ
Sci Rep; 2021 Dec; 11(1):23328. PubMed ID: 34857830
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting early-life intestinal microbiota development.
Vandenplas Y; Carnielli VP; Ksiazyk J; Luna MS; Migacheva N; Mosselmans JM; Picaud JC; Possner M; Singhal A; Wabitsch M
Nutrition; 2020 Oct; 78():110812. PubMed ID: 32464473
[TBL] [Abstract][Full Text] [Related]
20. Analytical characterization of human milk oligosaccharides - potential applications in pharmaceutical analysis.
Grabarics M; Csernák O; Balogh R; Béni S
J Pharm Biomed Anal; 2017 Nov; 146():168-178. PubMed ID: 28881314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
